# Caffeine inhibits nonhomologous end joining by impairing ligase IV/XRCC4 function

**Authors:** Susmita Kumari, Divya Sathees, Prashant Kumar Rai, Lipsa Rani Sahu, Sathees C Raghavan

PMC · DOI: 10.1093/nar/gkag182 · Nucleic Acids Research · 2026-03-03

## TL;DR

Caffeine inhibits DNA repair by blocking the function of a key protein complex involved in fixing DNA breaks.

## Contribution

This study reveals that caffeine directly inhibits DNA ligase IV/XRCC4 function, a novel mechanism for its DNA repair suppression.

## Key findings

- Caffeine inhibits nonhomologous end joining (NHEJ) in a concentration-dependent manner.
- Caffeine directly binds to XRCC4, disrupting its interaction with DNA ligase IV and impairing DNA repair.
- Disruption of caffeine's interaction site in XRCC4 partially restores DNA end joining in caffeine-treated cells.

## Abstract

DNA double-strand breaks (DSBs), the most lethal DNA lesions, are repaired primarily by homologous recombination (HR) or nonhomologous end joining (NHEJ). Caffeine is known to inhibit HR by displacing Rad51 from single-stranded DNA, but its impact on NHEJ was unclear. Here, we show that caffeine inhibits NHEJ in a concentration-dependent manner using biochemical and cellular assays. Increased 53BP1 and γ-H2AX foci upon caffeine exposure indicate inhibition of chromosomal NHEJ, leading to accumulation of DSBs. γ-H2AX immunofluorescence, neutral comet, and TUNEL assays revealed persistent DNA breaks and reduced repair. Mechanistically, in silico, biophysical, and biochemical analyses demonstrate that caffeine directly binds to XRCC4, disrupting its interaction with DNA ligase IV and thereby inhibiting repair. Biolayer interferometry confirmed caffeine–XRCC4 binding, with mutation of Thr133 reducing caffeine affinity and impairing XRCC4 recruitment to γ-H2AX–marked DSBs. Disruption of the predicted caffeine interaction site in XRCC4 (T133A) partially restored end joining in the presence of caffeine. Clonogenic survival assays showed decreased survival after caffeine treatment, more prominently in wild-type than in ligase IV–deficient cells. Immunodepletion and reconstitution experiments confirmed that caffeine specifically targets the ligase IV/XRCC4 complex. Thus, caffeine suppresses NHEJ by directly inhibiting ligase IV/XRCC4–mediated DNA end joining.

Graphical Abstract

## Linked entities

- **Proteins:** XRCC4 (X-ray repair cross complementing 4), ATLIG4 (DNA ligase IV), RAD51 (RAD51 recombinase), TP53BP1 (tumor protein p53 binding protein 1), H2AXA (Histone superfamily protein)
- **Chemicals:** caffeine (PubChem CID 2519)

## Full-text entities

- **Genes:** NHEJ1 (non-homologous end joining factor 1) [NCBI Gene 79840] {aka IMD124, MCOPCB13, XLF}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, POLM (DNA polymerase mu) [NCBI Gene 27434] {aka Pol Mu, Tdt-N}, ATM (ATM serine/threonine kinase) [NCBI Gene 472] {aka AT1, ATA, ATC, ATD, ATDC, ATE}, LIG4 (DNA ligase 4) [NCBI Gene 3981] {aka LIG4S}, RNASE1 (ribonuclease A family member 1, pancreatic) [NCBI Gene 6035] {aka RAC1, RIB1, RNS1}, RBBP8 (RB binding protein 8, endonuclease) [NCBI Gene 5932] {aka COM1, CTIP, JAWAD, JWDS, RIM, SAE2}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, TP53BP1 (tumor protein p53 binding protein 1) [NCBI Gene 7158] {aka 53BP1, TDRD30, p202, p53BP1}, DNTT (DNA nucleotidylexotransferase) [NCBI Gene 1791] {aka TDT}, XRCC5 (X-ray repair cross complementing 5) [NCBI Gene 7520] {aka KARP-1, KARP1, KU80, KUB2, Ku86, NFIV}, TAOK2 (TAO kinase 2) [NCBI Gene 9344] {aka MAP3K17, PSK, PSK1, PSK1-BETA, TAO1, TAO2}, RPA1 (replication protein A1) [NCBI Gene 6117] {aka HSSB, MST075, PFBMFT6, REPA1, RF-A, RP-A}, DNA2 (DNA replication helicase/nuclease 2) [NCBI Gene 1763] {aka DNA2L, RTS4, hDNA2}, PRKDC (protein kinase, DNA-activated, catalytic subunit) [NCBI Gene 5591] {aka DNA-PKC, DNA-PKcs, DNAPK, DNAPKc, DNPK1, HYRC}, RAD51 (RAD51 recombinase) [NCBI Gene 5888] {aka BRCC5, FANCR, HRAD51, HsRad51, HsT16930, MRMV2}, PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111] {aka ATLD2}, APLF (aprataxin and PNKP like factor) [NCBI Gene 200558] {aka APFL, C2orf13, PALF, Xip1, ZCCHH1}, BRCA2 (BRCA2 DNA repair associated) [NCBI Gene 675] {aka BRCC2, BROVCA2, FACD, FAD, FAD1, FANCD}, DOCK2 (dedicator of cytokinesis 2) [NCBI Gene 1794] {aka IMD40}, XRCC4 (X-ray repair cross complementing 4) [NCBI Gene 7518] {aka SSMED, hXRCC4}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, XRCC6 (X-ray repair cross complementing 6) [NCBI Gene 2547] {aka CTC75, CTCBF, G22P1, KU70, ML8, TLAA}, PAXX (PAXX non-homologous end joining factor) [NCBI Gene 286257] {aka C9orf142, XLS}, XRCC3 (X-ray repair cross complementing 3) [NCBI Gene 7517] {aka CMM6}, ATR (ATR checkpoint kinase) [NCBI Gene 545] {aka FCTCS, FRP1, MEC1, SCKL, SCKL1}
- **Diseases:** MMEJ (MESH:D003643), cervical cancer (MESH:D002583), leukemic (MESH:D007938), DSBs (MESH:D019457), cancer (MESH:D009369), acute lymphoblastic leukemia (MESH:D054198), cytotoxic (MESH:D064420), T-cell leukemia (MESH:D015458), Allergy (MESH:D004342), Infectious Diseases (MESH:D003141)
- **Chemicals:** TE (MESH:D013691), leupeptin (MESH:C032854), adenosine (MESH:D000241), DMEM (-), MgCl2 (MESH:D015636), propidium iodide (MESH:D011419), Sarkosyl (MESH:C025231), NaCl (MESH:D012965), potassium acetate (MESH:D019347), Trypan blue (MESH:D014343), methanol (MESH:D000432), crystal violet (MESH:D005840), Sephadex G25 (MESH:C025614), HEPES (MESH:D006531), glycerol (MESH:D005990), penicillin (MESH:D010406), Caffeine (MESH:D002110), dUTP (MESH:C027078), methylxanthine (MESH:C008514), diazabicyclo[2.2.2]octane (MESH:C578397), Phenylmethylsulfonyl fluoride (MESH:D010664), FITC (MESH:D016650), amino acid (MESH:D000596), EDTA (MESH:D004492), PEI (MESH:D011094), His (MESH:D006639), Triton X-100 (MESH:D017830), agar (MESH:D000362), boric acid (MESH:C032688), polyacrylamide (MESH:C016679), streptomycin (MESH:D013307), Alamar Blue (MESH:C005843), water (MESH:D014867), ATP (MESH:D000255), phenol (MESH:D019800), imidazole (MESH:C029899), CO2 (MESH:D002245), paraformaldehyde (MESH:C003043), nucleotides (MESH:D009711), lipid (MESH:D008055), glycogen (MESH:D006003), sucrose (MESH:D013395), chloroform (MESH:D002725), penicillin G (MESH:D010400), ammonium sulfate (MESH:D000645), agarose (MESH:D012685), KOH (MESH:C029943), PBS (MESH:D007854), DTT (MESH:D004229), Tween 20 (MESH:D011136), KCl (MESH:D011189), pepstatin (MESH:C031375), DABCO (MESH:C007306), HCl (MESH:D006851), PVDF (MESH:C024865), magnesium acetate (MESH:C000656591), SDS (MESH:D012967), RNS (MESH:D011886), isopropanol (MESH:D019840), acetic acid (MESH:D019342)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932]
- **Mutations:** C for 2-3, T133A
- **Cell lines:** HeLa LIV — Homo sapiens (Human), EBV-related Burkitt lymphoma, Cancer cell line (CVCL_W939), Jurkat — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0065), DH5alpha — Drosophila hydei (Fruit fly), Spontaneously immortalized cell line (CVCL_Z531), E. coli — Mus musculus (Mouse), Hybridoma (CVCL_C5CR), pET-28a — Oryctolagus cuniculus (Rabbit), Transformed cell line (CVCL_6E94), MMEJ — Homo sapiens (Human), Somatic stem cell (CVCL_WG35), HMF-3S — Homo sapiens (Human), Conditionally immortalized cell line (CVCL_4U96), (DE3 — Mus musculus (Mouse), Hybridoma (CVCL_B7HM), HeLa — Homo sapiens (Human), Human papillomavirus-related cervical squamous cell carcinoma, Cancer cell line (CVCL_T292), Molt4 — Homo sapiens (Human), Adult T acute lymphoblastic leukemia, Cancer cell line (CVCL_0013)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12956356/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12956356/full.md

## References

80 references — full list in the complete paper: https://tomesphere.com/paper/PMC12956356/full.md

---
Source: https://tomesphere.com/paper/PMC12956356